Skip to main content
SpringerLink
Log in

Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Our purpose was to define the effect of pretreatment Helicobacter pylori resistance to metronidazole or to clarithromycin on the success of antimicrobial therapy. We used 75 key words to perform a literature search in MEDLINE as well as manual searches to identify clinical treatment trials that provided results in relation to H. pylori susceptibility to metronidazole and clarithromycin or both during the period 1984–1997 (abstracts were not included). Meta-analysis was done with both fixed- and random-effect models; results were shown using Galbraith's radial plots. We identified 49 papers with 65 arms for metronidazole (3594 patients, 2434 harboring H. pylori strains sensitive to metronidazole and 1160 harboring resistant strains). Metronidazole resistance reduced effectiveness by an average of 37.7% (95% CI = 29.6–45.7%). The variability in the risk difference for metronidazole was 122.0 to −90.6 and the chi-square value for heterogeneity was significant (P < 0.001). Susceptibility tests for clarithromycin were performed in 12 studies (501 patients, 468 harboring H. pylori strains sensitive to clarithromycin and 33 harboring resistant strains). Clarithromycin resistance reduced effectiveness by an average of 55% (95% CI = 33–78%). We found no common factors that allowed patients to be divided into subgroups with additional factors significantly associated with resistance. In conclusion, metronidazole or clarithromycin pretreatment resistant H. pylori are the main factors responsible for treatment failure with regimens using these compounds. If H. pylori antibiotic resistance continues to increase, pretherapy antibiotic sensitivity testing might become necessary in many regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Anonymous: Gastroenterologist in Sydney-histology and Helicobacter. Lancet 336:779-780, 1990

  2. O'Riordan T, Mathai E, Tobin A, McKenna D, Keane C, Sweeney E, O'Morain C: Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 31:999-1002, 1990

    PubMed  Google Scholar 

  3. Megraud F: Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 11 (suppl 1):43-53, 1997

    PubMed  Google Scholar 

  4. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Alpert LC, Genta RM: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102:493-496, 1992

    PubMed  Google Scholar 

  5. Realdi G, Dore MP, Piana A, Atzei A, Carta M, Cugia L, Manca A, Are BM, Massarelli G, Mura I, Maida A, Graham DY: Pre-treatment antibiotic resistance in Helicobacter pylori infection: Results of three randomized, controlled studies. Helicobacter 4:106-112, 1999

    PubMed  Google Scholar 

  6. Glupczynski Y, Burette A: Drug therapy for Helicobacter pylori infection: Problems and pitfalls. Am J Gastroenterol 85:1545-1551, 1990

    PubMed  Google Scholar 

  7. Glupczynski Y: European Multicentre Study Group on antibiotic susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 11:777-781, 1992

    PubMed  Google Scholar 

  8. Haas CE, Nix DE, Shentag JJ: In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 34:1637-1641, 1990

    PubMed  Google Scholar 

  9. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourne S, Phillips M: Prevention of nitroimidazole resistance in Campylobacter pyloridis by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies. J Clin Pathol 41:207-210, 1988

    PubMed  Google Scholar 

  10. Graham DY, Dore MP: Variability in the outcome of treatment of Helicobacter pylori infection: A critical analysis. In Helicobacter pylori Basic Mechanisms to Clinical Cure 1998. RH Hunt and GNJ Tytgat (eds). Kluwer Academic Publishers, Dordrecht, The Netherlands, 1998, pp 426-441

    Google Scholar 

  11. Graham DY: Antibiotic resistance in Helicobacter pylori: Implications for therapy. Gastroenterology 115:1272-1277, 1998

    PubMed  Google Scholar 

  12. Graham DY, de Boer WA, Tytgat GN: Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 91:1072-1076, 1996

    PubMed  Google Scholar 

  13. Galbraith RF: A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7:889-894, 1988

    PubMed  Google Scholar 

  14. META: The Right Handbook and Software to Understand and Practice Meta-Analysis. G. Leandro (eds). www.Media.it/META (in progress)

  15. Xia H, Keane CT, Beattie S, O'Morain CA: Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 38:2357-2361, 1994

    PubMed  Google Scholar 

  16. Rautelin H, Seppala K, Renkonen OV, Vainio U, Kosunen TU: Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 36:163-166, 1992

    PubMed  Google Scholar 

  17. Lerang F, Moum B, Haug JB, Tolas P, Breder O, Aubert E, Hoie O, Soberg T, Flaaten B, Farup P, Berge T: Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 92:248-253, 1997

    PubMed  Google Scholar 

  18. Fraser AG, Moore L, Ali MR, Chua LE, Hollis B, Little SV: An audit of low dose triple therapy for eradication of Helicobacter pylori: NZ Med J 109:290-292, 1996

    Google Scholar 

  19. Ching CK, Leung KP, Yung RW, Lam SK, Wong BC, Lai KC: Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 38:675-678, 1996

    PubMed  Google Scholar 

  20. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CM: Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 142:37-42, 1996

    PubMed  Google Scholar 

  21. de Boer WA, van Etten RJ, Schade RW, Ouwehand ME, Schneeberger PM, van Unnik AJ, Tytgat GN: One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 11:109-112, 1997

    Google Scholar 

  22. Thijs JC, Van Zwet AA, Thijs WJ, Van der Wouden EJ, Kooy A: One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance. Aliment Pharmacol Ther 11:305-309, 1997

    PubMed  Google Scholar 

  23. Yousfi MM, el-Zimaity HM, al-Assi MT, Cole RA, Genta RM, Graham DY: Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 9:209-212, 1995

    PubMed  Google Scholar 

  24. Bell GD, Powell KU, Burridge SM, Bowden AN, Rameh B, Bolton G, Purser K, Harrison G, Brown C, Gant PW, Jones PH, Trowell JE: Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 86:743-750, 1993

    PubMed  Google Scholar 

  25. Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, Jones PH, Brown C: Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 9:41-46, 1995

    Google Scholar 

  26. Seppala K, Farkkila M, Nuutinen H, Hakala K, Vaananen H, Rautelin H, Kosunen TU: Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol 27:973-976, 1992

    PubMed  Google Scholar 

  27. Thijs JC, Van Zwet AA, Oey HB: Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 28:934-938, 1993

    PubMed  Google Scholar 

  28. Hosking SW, Ling TK, Chung SC, Yung MY, Cheng AF, Sung JJ, Li AK: Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomized controlled trial. Lancet 343:508-510, 1994

    Article  PubMed  Google Scholar 

  29. de Boer WA, Driessen WM, Jansz AR, Tytgat GN: Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: Results of a randomized prospective single-center study. Eur J Gastroenterol Hepatol 7:1189-1194, 1995

    PubMed  Google Scholar 

  30. de Boer WA, Driessen W, Jansz A, Tytgat GN: Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 345:817-820, 1995

    Article  PubMed  Google Scholar 

  31. Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GN: Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 26:321-327, 1994

    PubMed  Google Scholar 

  32. Lynch DA, Sobala GM, Gallacher B, Dixon MF, Axon AT: Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori. J Antimicrob Chemother 33:877-879, 1994

    PubMed  Google Scholar 

  33. Labenz J, Peitz U, Tillenburg B, Becker T, Borsch G, Stolte M: Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori. Leber Magen Darm 25:122-127, 1995

    PubMed  Google Scholar 

  34. Logan RP, Gummett PA, Schaufelberger HD, Greaves RR, Mendelson GM, Walker MM, Thomas PH, Baron JH, Misiewicz JJ: Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 35:323-326, 1994

    PubMed  Google Scholar 

  35. Wyeth JW, Pounder RE, Duggan AE, O'Morain CA, Schaufelberger HD, De Koster EH, Rauws EA, Bardhan KD, Gilvarry J, Buckley MJ, Gummett PA, Logan RP: The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 10:623-630, 1996

    PubMed  Google Scholar 

  36. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, Taufer M, Wurzer H: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328:308-312, 1993

    PubMed  Google Scholar 

  37. Moayyedi P, Sahay P, Tompkins DS, Axon AT: Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol 7:835-840, 1995

    Google Scholar 

  38. Thijs JC, van Zwet AA, Moolenaar W, Wolfhagen MJ, ten Bokkel Huinink J: Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: A multicenter, prospective, randomized, controlled study of efficacy and side effects. Am J Gastroenterol 91:93-97, 1996

    PubMed  Google Scholar 

  39. Bell GD, Powell K, Burridge SM, Pallecaros A, Jones PH, Gant PW, Harrison G, Trowell JE. Experience with "triple" anti-Helicobacter pylori eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 6:427-435, 1992

    PubMed  Google Scholar 

  40. Logan RP, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH: One week eradication regimen for Helicobacter pylori. Lancet 338:1249-1252, 1991

    PubMed  Google Scholar 

  41. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, Stratton CW, Drnec J, Prokocimer P, Siepman N: Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial. Am J Gastroenterol 88:1860-1864, 1993

    PubMed  Google Scholar 

  42. de Boer WA, Driessen WM, Tytgat GN: Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 9:633-638, 1995

    PubMed  Google Scholar 

  43. Gotoh A, Kawakami Y, Akahane T, Akamatsu T, Shimizu T, Kiyosawa K, Katsuyama T: Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiol Immunol 41:7-12, 1997

    PubMed  Google Scholar 

  44. Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP, Bae H: Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 37:477-481, 1995

    PubMed  Google Scholar 

  45. de Boer WA, van Etten RJ, Schade RW, Ouwehand ME, Schneeberger PM, Tytgat GN: 4-Day lansoprazole quadruple therapy: A highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 91:1778-1782, 1996

    PubMed  Google Scholar 

  46. Gisbert JP, Boixeda D, de Rafael L, Martin de Argila C, Bermejo F, Garcia Plaza A: The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later. Rev Esp Enferm Dig 87:193-198, 1995

    PubMed  Google Scholar 

  47. Schütze K, Hentschel E, Hirschl AM: Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia. Eur J Gastroenterol Hepatol 8:41-46, 1996

    PubMed  Google Scholar 

  48. Glupczynski Y, Burette A, De Koster E, Nyst JF, Deltenre M, Cadranel S, Bourdeaux L, De Vos D: Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977, 1990

    Google Scholar 

  49. Bell GD, Powell KU: Helicobacter pylori reinfection after apparent eradication-the Ipswich experience. Scand J Gastroenterol 215(suppl 31):96-104, 1996

    Google Scholar 

  50. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL: Metronidazole susceptibility testing for Helicobacter pylori: Comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol 31:1971-1974, 1993

    PubMed  Google Scholar 

  51. Weil J, Bell GD, Powell K, Morden A, Harrison G, Gant PW, Jones PH, Trowell JE: Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther 4:651-657, 1990

    PubMed  Google Scholar 

  52. Glupczynski Y, Burette A: Eradicating Helicobacter pylori. Lancet 339:54-55, 1992

    Google Scholar 

  53. Gisbert JP, Boixeda D, de Rafael L, Redondo C, Martin de Argila C, Bermejo F: Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori. Rev Esp Enferm Dig 88:317-322, 1996

    PubMed  Google Scholar 

  54. Midolo PD, Lambert JR, Turnidge J: Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 11:290-292, 1996

    PubMed  Google Scholar 

  55. Xia H, Daw MA, Sant S, Beattie S, Keane CT, O'Morain CA: Clinical efficacy of triple therapy in Helicobacter pyloriassociated duodenal ulcer. Eur J Gastroenterol Hepatol 5:141-144, 1993

    Google Scholar 

  56. Harris AW, Pryce DI, Gabe SM, Karim QN, Walker MM, Langworthy H, Baron JH, Misiewicz JJ: Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment Pharmacol Ther 10:1005-1008, 1996

    PubMed  Google Scholar 

  57. Powell KU, Bell GD, Boweden AF, Trowell JE, Jones PH: Helicobacter pylori eradication therapy: A comparison between either omeprazole or ranitidine in combination with amoxicillin plus metronidazole. Br J Clin Res 6:163-169, 1995

    Google Scholar 

  58. Moayyedi P, Langworthy H, Shanahan K, Tompkins DS, Dixon MF, Chalmers DM, Axon AT: Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. Helicobacter 1:71-74, 1996

    PubMed  Google Scholar 

  59. Schwartz H, Krause R, Siepman N, Haber M, Weissfeld A, Kidd S, Rose P, Sahba B: Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report. Helicobacter 1:251-255, 1996

    PubMed  Google Scholar 

  60. Tompkins DS, Perkin J, Smith C: Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 2:185-187, 1997

    PubMed  Google Scholar 

  61. Tucci A, Corinaldesi R, Stanghellini V, Paparo GF, Gasperoni S, Biasco G, Varoli O, Ricci-Maccarini M, Barbara L: One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci 38:1670-1673, 1993

    PubMed  Google Scholar 

  62. Thijs JC, Van Zwet AA, Moolenaar W, Oom JA, De Korte H, Runhaar: Short report: Clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. Aliment Pharmacol Ther 8:131-134, 1994

    PubMed  Google Scholar 

  63. Stupnicki T, Taufer M, Denk H, Ratschek M, Spath P, Graf K: Triple therapy with sucralfate, amoxycillin and metronidazole for healing duodenal ulcer and eradicating Helicobacter pylori infection. Aliment Pharmacol Ther 10:193-197, 1996

    PubMed  Google Scholar 

  64. Logan RP, Bardhan KD, Celestin LR, Theodossi A, Palmer KR, Reed PI, Baron JH, Misiewicz JJ: Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 9:417-442, 1995

    PubMed  Google Scholar 

  65. van der Hulst RWM, Weel JF, van der Ende A, ten Kate FJ, Dankert J, Tytgat GN: Therapeutic options after failed Helicobacter pylori eradication therapy. Am J Gastroenterol 91:2333-2337, 1996

    PubMed  Google Scholar 

  66. Lerang F, Moum B, Ragnhildstveit E, Haug JB, Hauge T, Tolas P, Aubert E, Henriksen M, Efskind PS, Nicolaysen K, Soberg T, Odegaard A, Berge T: A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-yr follow-up study. Am J Gastroenterol 92:653-658, 1997

    PubMed  Google Scholar 

  67. Vautier G, Scott BB: A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice. Aliment Pharmacol Ther 11:107-108, 1997

    PubMed  Google Scholar 

  68. Breuer T, Kim JG, Gurer IE, Graham DP, Osato M, Genta RM, Graham DY: Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 11:523-527, 1997

    PubMed  Google Scholar 

  69. Witteman EM, Hopman WP, Becx MC, De Koning RW, Tytgat GN, Janssen AJ, Jansen JB: Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis. Aliment Pharmacol Ther 7:683-687, 1993

    PubMed  Google Scholar 

  70. Versalovic J, Osato MS, Spakovsky K, Dore MP, Reddy R, Stone GG, Shortridge D, Flamm RK, Tanaka SK, Graham DY: Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 40:283-286, 1997

    PubMed  Google Scholar 

  71. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J, Idler K, Zulawinski L, Tanaka SK: Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1:227-228, 1996

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA Medical Center and Baylor College of Medicine, Houston, Texas

    Maria Pina Dore, Gioacchino Leandro, Giuseppe Realdi, Antonia Rogado Sepulveda & David Yates Graham

  2. Department of Internal Medicine, University of Sassari, Sassari, Italy

    Maria Pina Dore, Gioacchino Leandro, Giuseppe Realdi, Antonia Rogado Sepulveda & David Yates Graham

  3. IRCCS “S. De Bellis,” Castellana Grotte, Bari, Italy

    Maria Pina Dore, Gioacchino Leandro, Giuseppe Realdi, Antonia Rogado Sepulveda & David Yates Graham

Authors
  1. Maria Pina Dore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gioacchino Leandro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Realdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonia Rogado Sepulveda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Yates Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dore, M.P., Leandro, G., Realdi, G. et al. Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy. Dig Dis Sci 45, 68–76 (2000). https://doi.org/10.1023/A:1005457226341

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005457226341

Search

Navigation